Sulfanilamides are applied as antimicrobal agents in clinical practice. Sulfanilamide treatment, however, can result in hemolytic anemia development in patients that suffer from genetic defect of the following enzyme of pentose phosphate metabolism in erythrocytes:

Question

Answer options

Correct answer

This educational archive is provided by KROKEXAM and is not an official testing authority publication.